GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jointown Pharmaceutical Group Co Ltd (SHSE:600998) » Definitions » Interest Expense

Jointown Pharmaceutical Group Co (SHSE:600998) Interest Expense : ¥-1,292 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Jointown Pharmaceutical Group Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Jointown Pharmaceutical Group Co's interest expense for the three months ended in Mar. 2024 was ¥ -316 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1,292 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Jointown Pharmaceutical Group Co's Operating Income for the three months ended in Mar. 2024 was ¥ 1,110 Mil. Jointown Pharmaceutical Group Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -316 Mil. Jointown Pharmaceutical Group Co's Interest Coverage for the quarter that ended in Mar. 2024 was 3.52. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Jointown Pharmaceutical Group Co Interest Expense Historical Data

The historical data trend for Jointown Pharmaceutical Group Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jointown Pharmaceutical Group Co Interest Expense Chart

Jointown Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,240.45 -1,027.44 -1,145.27 -1,221.47 -1,317.64

Jointown Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -341.46 -335.35 -353.06 -287.78 -315.54

Jointown Pharmaceutical Group Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1,292 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jointown Pharmaceutical Group Co  (SHSE:600998) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jointown Pharmaceutical Group Co's Interest Expense for the three months ended in Mar. 2024 was ¥-316 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥1,110 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥2,180 Mil.

Jointown Pharmaceutical Group Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*1109.673/-315.536
=3.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Jointown Pharmaceutical Group Co (SHSE:600998) Business Description

Traded in Other Exchanges
N/A
Address
No 8 Longyang Road, Hanyang District, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.
Executives
Liu Yi Chang Director
Ai Hua Director
Wang Qi Bing senior management
Gong Yi Hua Directors, senior managers
Lin Xin Yang Directors, senior managers
Yang Ju Mei senior management
Chen Qi Ming Directors, senior managers
Chen Li Supervisors
Guo Lei senior management
Liu Su Fang senior management
Xu Ming Zhen senior management
Chen Song Bai senior management
Huang Li Hua senior management
Wang Jia Ming senior management
Chen Bo senior management

Jointown Pharmaceutical Group Co (SHSE:600998) Headlines

No Headlines